Please login to the form below

Not currently logged in
Email:
Password:

targeting

This page shows the latest targeting news and features for those working in and with pharma, biotech and healthcare.

ICR research shows how skin cancer cells invade new tissues

ICR research shows how skin cancer cells invade new tissues

Targeting a specific gene could lead to treatments that prevent cancer from spreading. ... The scientists believe that, in the future, targeting the gene could lead to treatments that prevent cancer from spreading.

Latest news

More from news
Approximately 2 fully matching, plus 942 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 168 partially matching documents found.

Latest appointments

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    Arrakis Therapeutics . Arrakis Therapeutics, a biopharmaceutical company focused on the discovery of new-class small molecules medicines targeting RNA, has appointed Katrine Bosley (pictured below, right) as. ... Katrine’s experience building dynamic,

  • F-star hires ex-BMS immuno-oncology leader

    Hewill oversee the clinical development of F-star’s lead product candidate, FS118, a LAG-3/PD-L1-targeting tetravalent bispecific antibody currently in aphase 1 clinical trial, recruiting the  expansion

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;

  • Industry appointments Industry appointments

    Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma

  • Professor Thomas Cech joins Storm Therapeutics Professor Thomas Cech joins Storm Therapeutics

    mature into a world leading therapeutics company targeting RNA epigenetic modulation.”.

More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest from PMHub

  • Genesis Research Acquires Market Access Transformation Genesis Research Acquires Market Access Transformation

    We apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalisation to build market leading businesses of strategic global value.

  • What does the future hold for clinical trial recruitment?

    This work is ongoing as the virus mutates; last month, it was announced that  Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant. ... But more recently – driven by Facebook’s data privacy issues –

  • Ad tracking: the end of the road? Ad tracking: the end of the road?

    This lack of data will make it difficult to capture interactions with ads, and since January 19th, it has been further complicated by Facebook deciding to remove detailed targeting options. ... 3. Summary. It’s clear that targeting on all the major ad

  • GHO Capital Acquires Genesis Research GHO Capital Acquires Genesis Research

    We apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalization to build market leading businesses of strategic global value.

  • Data-driven healthcare communications

    Connect: Through rigorous targeting and segmentation, we were able to appeal to those who may be eligible for vaccination and prioritise our target audience to develop a highly focused campaign that

More from PMHub
Approximately 2 fully matching, plus 79 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...